Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Non-Current Liabilities: 2024

Historic Other Non-Current Liabilities for Eton Pharmaceuticals (ETON) over the last 1 years, with Dec 2024 value amounting to $1.8 million.

  • Eton Pharmaceuticals' Other Non-Current Liabilities was N/A to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Other Non-Current Liabilities is $1.8 million.
  • Eton Pharmaceuticals' 5-year Other Non-Current Liabilities high stood at $1.8 million for FY2024, and its period low was $1.8 million during FY2024.
  • Its 1-year average for Other Non-Current Liabilities is $1.8 million, with a median of $1.8 million in 2024.